美国FDA 指导原则 公众警告-根据21 CFR第7部分C分部行业和FDA工作人员指南的召回通知 英文原版.pdfVIP

Public Warning and Notification of Recalls Under 21 CFR Part 7, Subpart C Guidance for Industry and FDA Staff You may submit electronic or written comments regarding this guidance at any time. Submit electronic comments to . Submit written comments to the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number FDA-2016- D-3548. For questions or information regarding this guidance, contact the Office of Regulatory Affairs (ORA), Offic